Pharmaceutical composition having immunomodulating activity
    3.
    发明授权
    Pharmaceutical composition having immunomodulating activity 失效
    具有免疫调节活性的药物组合物

    公开(公告)号:US4581371A

    公开(公告)日:1986-04-08

    申请号:US476499

    申请日:1983-03-18

    申请人: Massimo Baldacci

    发明人: Massimo Baldacci

    CPC分类号: A61K31/195 A61K31/40

    摘要: The administration by oral route of a composition comprising arginine pyrrolidone carboxylate and lysine pyrrolidone carboxylate at a dose of 150 to 200 mg/kg of body weight has immunomodulating activity capable of restoring depressed immunodefenses.

    摘要翻译: 以150-200mg / kg体重的剂量通过口服途径施用包含精氨酸吡咯烷酮羧酸盐和赖氨酸吡咯烷酮羧酸盐的组合物具有能够恢复抑制性免疫反应的免疫调节活性。

    Pyrrolidone carboxylic acid (PCA) for ophthalmic use

    公开(公告)号:US10456374B2

    公开(公告)日:2019-10-29

    申请号:US16297398

    申请日:2019-03-08

    发明人: Massimo Baldacci

    摘要: The present invention relates to pyrrolidone carboxylic acid (PCA) and/or pharmaceutically acceptable salts or derivatives thereof for use in the treatment of ocular diseases and/or disorders.A further object of the present invention are compositions comprising pyrrolidone carboxylic acid (PCA) and/or pharmaceutically acceptable salts or derivatives thereof, at least one physiologically acceptable excipient, and optionally at least one additional active ingredient for use in the treatment of ocular diseases and/or disorders.

    Pyrrolidone carboxylic acid (PCA) for ophthalmic use

    公开(公告)号:US10272067B2

    公开(公告)日:2019-04-30

    申请号:US15558524

    申请日:2016-04-06

    发明人: Massimo Baldacci

    摘要: The present invention relates to pyrrolidone carboxylic acid (PCA) and/or pharmaceutically acceptable salts or derivatives thereof for use in the treatment of ocular diseases and/or disorders.A further object of the present invention are compositions comprising pyrrolidone carboxylic acid (PCA) and/or pharmaceutically acceptable salts or derivatives thereof, at least one physiologically acceptable excipient, and optionally at least one additional active ingredient for use in the treatment of ocular diseases and/or disorders.